• 2013

Company Description

Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs.

Myelo Therapeutics is focused on the development of treatments for a range of medical needs. It offers myelo001, a molecule that is effective on the hematogenesis. Myelo Therapeutics was founded by Till Erdmann in 2013. It is based in Berlin, Germany.